Meanwhile, matrix metalloproteinase-9 (MMP-9) facilitates extracellular matrix degradation and has been implicated in BBB disruption, peripheral-to-central cytokine trafficking, and depression-related neuroinflammatory processes (10, 11). Here, MMP9 is linked to depressive symptom measurement.